| 1 |
33603473 | Development and Validation of a Nomogram for the Estimation of Response to Platinum-Based Neoadjuvant Chemotherapy in Patients with Locally Advanced Cervical Cancer. | 2021 |
1 |
| 2 |
31818526 | Survival outcome and perioperative complication related to neoadjuvant chemotherapy with carboplatin and paclitaxel for advanced ovarian cancer: A systematic review and meta-analysis. | 2020 May |
1 |
| 3 |
32774215 | Optimal Systemic Treatment for Early Triple-Negative Breast Cancer. | 2020 Jun |
1 |
| 4 |
27603388 | Effect of neoadjuvant chemotherapy on platinum resistance in stage IIIC and IV epithelial ovarian cancer. | 2016 Sep |
5 |
| 5 |
24463159 | TP53 K351N mutation-associated platinum resistance after neoadjuvant chemotherapy in patients with advanced ovarian cancer. | 2014 Mar |
1 |
| 6 |
23337490 | Platinum resistance after neoadjuvant chemotherapy compared to primary surgery in patients with advanced epithelial ovarian carcinoma. | 2013 Apr |
6 |
| 7 |
22333992 | Changes in serum CA-125 can predict optimal cytoreduction to no gross residual disease in patients with advanced stage ovarian cancer treated with neoadjuvant chemotherapy. | 2012 May |
1 |
| 8 |
20187069 | The role of neoadjuvant chemotherapy in treating advanced epithelial ovarian cancer. | 2010 Mar 15 |
1 |